ADVANTAGE INVESTMENT MANAGEMENT, LLC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 162 filers reported holding IMMUNOGEN INC in Q2 2016. The put-call ratio across all filers is 1.00 and the average weighting 0.0%.

Quarter-by-quarter ownership
ADVANTAGE INVESTMENT MANAGEMENT, LLC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q1 2018$5,000
+66.7%
5000.0%0.00%
+100.0%
Q4 2017$3,000
-25.0%
5000.0%0.00%0.0%
Q3 2017$4,0000.0%5000.0%0.00%0.0%
Q2 2017$4,000
+100.0%
5000.0%0.00%0.0%
Q1 2017$2,000
+100.0%
5000.0%0.00%
Q4 2016$1,0000.0%5000.0%0.00%
Q3 2016$1,000
-50.0%
5000.0%0.00%
-100.0%
Q2 2016$2,000
-50.0%
5000.0%0.00%
-50.0%
Q1 2016$4,000
-42.9%
5000.0%0.00%
-50.0%
Q4 2015$7,000
+40.0%
5000.0%0.00%
+33.3%
Q3 2015$5,000
-64.3%
500
-50.0%
0.00%
-57.1%
Q2 2015$14,000
+55.6%
1,0000.0%0.01%
+40.0%
Q1 2015$9,0001,0000.01%
Other shareholders
IMMUNOGEN INC shareholders Q2 2016
NameSharesValueWeighting ↓
Redmile Group, LLC 3,984,734$15,421,0001.00%
Moloney Securities Asset Management, LLC 274,450$1,062,0000.55%
Schonfeld Strategic Advisors LLC 1,025,176$3,968,0000.40%
Orbimed Advisors 6,095,647$23,590,0000.27%
TWIN FOCUS CAPITAL PARTNERS, LLC 113,216$438,0000.26%
PINNACLE ASSOCIATES LTD 1,589,959$6,153,0000.12%
Baker Brothers Advisors 3,015,353$11,669,0000.10%
BAXTER BROS INC 58,000$224,0000.07%
SIMON QUICK ADVISORS, LLC 25,000$97,0000.06%
ClearBridge Investments 14,428,856$55,840,0000.06%
View complete list of IMMUNOGEN INC shareholders